Roche has been praised for its handling of the acquisition of biotech company Genentech Inc., which it has managed to keep at an arm’s length and in which it has continued to foster a biotech spirit. Over a decade ago, in 2009, Roche purchased full ownership of Genentech for $46.8bn, however it had owned a majority stake in the company since 1990.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?